1331 related articles for article (PubMed ID: 15861527)
1. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
[TBL] [Abstract][Full Text] [Related]
2. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
3. Juvenile mycosis fungoides treated with bexarotene and PUVA.
Rodríguez-Vázquez M; García-Arpa M; González-García J
Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous presentations of lymphoma in human immunodeficiency virus disease. Predominance of T cell lineage.
Kerschmann RL; Berger TG; Weiss LM; Herndier BG; Abrahms KM; Heon V; Schulze K; Kaplan LD; Resnik SD; LeBoit PE
Arch Dermatol; 1995 Nov; 131(11):1281-8. PubMed ID: 7503572
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma.
Yoshino T; Nakamura S; Matsuno Y; Ochiai A; Yokoi T; Kitadai Y; Suzumiya J; Tobinai K; Kobayashi Y; Oda I; Mera K; Ohtsu A; Ishikura S
Cancer Sci; 2006 Feb; 97(2):163-6. PubMed ID: 16441428
[TBL] [Abstract][Full Text] [Related]
6. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-negative Hodgkin's lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin.
Kremer M; Sandherr M; Geist B; Cabras AD; Höfler H; Fend F
Mod Pathol; 2001 Feb; 14(2):91-7. PubMed ID: 11235910
[TBL] [Abstract][Full Text] [Related]
8. [Aggressive cutaneous T-cell lymphoma associated with the presence of Epstein-Barr virus. 2 cases].
Mouly F; Baccard M; Rybojad M; Lebbé C; Morinet F; Morel P
Ann Dermatol Venereol; 1996; 123(9):574-6. PubMed ID: 9615113
[TBL] [Abstract][Full Text] [Related]
9. [Mycosis fungoides following non-Hodgkin's cutaneous B-cell lymphoma].
Dereure O; Basset-Seguin N; Guilhou JJ
Ann Dermatol Venereol; 1993; 120(9):625-7. PubMed ID: 8161118
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus positivity in primary vaginal lymphoma.
Domingo S; Perales A; Torres V; Alcaraz MJ; Pellicer A
Gynecol Oncol; 2004 Dec; 95(3):719-21. PubMed ID: 15581989
[TBL] [Abstract][Full Text] [Related]
11. [Primary and isolated cutaneous lymphomatoid granulomatosis following heart-lung transplantation].
Tas S; Simonart T; Dargent J; Kentos A; Antoine M; Knoop C; Estenne M; De Dobbeleer G
Ann Dermatol Venereol; 2000 May; 127(5):488-91. PubMed ID: 10863178
[TBL] [Abstract][Full Text] [Related]
12. Absence of Epstein-Barr viral encoded RNA (EBER) in primary cutaneous t-cell lymphoma.
Angel CA; Slater DN; Royds JA; Nelson SN; Bleehen SS
J Pathol; 1996 Feb; 178(2):173-5. PubMed ID: 8683385
[TBL] [Abstract][Full Text] [Related]
13. Aggressive B-cell lymphoma induced by Epstein-Barr virus infection in erythrodermic cutaneous T-cell lymphoma.
Kikuchi A; Anzai H; Kosuge H; Naka W; Nishikawa T
Br J Dermatol; 1997 Jan; 136(1):124-8. PubMed ID: 9039311
[TBL] [Abstract][Full Text] [Related]
14. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
15. EBV+ cutaneous B-cell lymphoproliferation of the leg in an elderly patient with mycosis fungoides and methotrexate treatment.
Rausch T; Cairoli A; Benhattar J; Spring P; Hohl D; de Leval L
APMIS; 2013 Jan; 121(1):79-84. PubMed ID: 23031074
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
[TBL] [Abstract][Full Text] [Related]
17. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
[TBL] [Abstract][Full Text] [Related]
18. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
[TBL] [Abstract][Full Text] [Related]
19. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
20. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
